The anti-viral immune regulators STING (STimulator of INterferon Genes) and NF-kB have been indicated in mammalian studies to respond to unmitigated mitochondria damage linked to mutations in quality control pathways such as the Parkinson’s Disease-associated Pink1/Parkin pathway. This evidence concerns the gene STING1 and Parkinson disease.